ABBV Abbvie Inc.

Five-factor quant read, peer ranking, and the analyst team's own call.

3.9
composite/ 10
Value computed
3.2

priced for 10.4% growth vs 1.8% delivered · -42% to base-case fair value

Quality computed
5.3

Piotroski 6/8 · Altman grey zone · ROE -129% · interest covered 3x

Momentum rank
2.0

shallow recent drawdowns · pressing its 52-week high

Defensive rank
8.0
Tactical rank
1.0

Descriptive, not predictive. Momentum, Defensive and Tactical are deciles within our liquid universe; Value and Quality are computed from filed financials. None of them forecasts a return - the model's out-of-sample AUC is published in the whitepaper. Deciles as of 2026-09-02.

Peer comparison

Composite score against sector peers · 5 names

#1
7.8
#2
7.7
#3
6.4
#4
6.2
#5
3.9

ABBV ranks #5 of 5 · peer average 6.4

No current desk call on ABBV. The factor scores above are computed; a full analysis is four analyst desks, a bull-vs-bear debate and a risk committee, and takes about three minutes.

Automated, educational research - not investment advice, and not a recommendation to buy or sell any security.